Twenty-six hours post-infection, stable pools of cells were selected with 1.2 g/mL puromycin (Invitrogen, San Diego, USA) for MCF-7 cells and 1.4 g/mL puromycin for ZR-75-1 cells for 3 days or 100 g/mL hygromycin for MCF-7 and ZR-75-1 cells for 7 days before being used for subsequent experiments
Results: Immediately post-injury, and at 1, 2, 3, 5, 7, 14, 21, 28, 60, and 90 days post-injury, quadriceps muscle-to-bone detachment showed definitive healing failure (impaired walking and permanent knee flexure)
Current and emerging targeted therapies for spinal muscular atrophy
No body weight changes in the offspring were noted at 300 mg/kg/day, where maternal systemic exposure (AUC24) was approximately 6 times higher than clinical exposures at the approved human dose of PAXLOVID
Knight 2013)